Immunomedics
Executive Summary
David Goldenberg takes over CEO position following resignation of President & CEO Robert DeLuccia, the company announces June 2. DeLuccia will remain at the company in an advisory position during the management transition. Goldenberg, founder of the Morris Plains, N.J.-based biopharm company, served as Immunomedics CEO in the past. The company also names Immunomedics Europe General Manager Philippe Barzin VP-global marketing and business development at U.S. headquarters
David Goldenberg takes over CEO position following resignation of President & CEO Robert DeLuccia, the company announces June 2. DeLuccia will remain at the company in an advisory position during the management transition. Goldenberg, founder of the Morris Plains, N.J.-based biopharm company, served as Immunomedics CEO in the past. The company also names Immunomedics Europe General Manager Philippe Barzin VP-global marketing and business development at U.S. headquarters. |